Daniel Ferreira, PhD, Assistant Professor
Daniel Ferreira, PhD, Assistant Professor
Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics, Karolinska
Підтверджена електронна адреса в ki.se - Домашня сторінка
Назва
Посилання
Посилання
Рік
Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers
M Schöll, A Wall, S Thordardottir, D Ferreira, N Bogdanovic, B Långström, ...
Neurology 79 (3), 229-236, 2012
1102012
Meta-review of CSF core biomarkers in Alzheimer’s disease: the state-of-the-art after the new revised diagnostic criteria
D Ferreira, L Perestelo-Perez, E Westman, LO Wahlund, A Sarria, ...
Frontiers in aging neuroscience 6 (article 47), 1-24, 2014
922014
Distinct subtypes of Alzheimer’s disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications
D Ferreira, C Verhagen, JA Hernández-Cabrera, L Cavallin, CJ Guo, ...
Scientific Reports 7 (46263), 2017
802017
Targeted delivery of NGF to the cholinergic basal forebrain of Alzheimer's disease patients: Application of a second generation encapsulated cell biodelivery device
Alzheimers Res Ther, In-press, 2016
73*2016
Practical cut‐offs for visual rating scales of medial temporal, frontal and posterior atrophy in A lzheimer's disease and mild cognitive impairment
D Ferreira, L Cavallin, EM Larsson, JS Muehlboeck, P Mecocci, B Vellas, ...
Journal of internal medicine 278 (3), 277-290, 2015
722015
Brain Changes in Alzheimer's Disease Patients with Implanted Encapsulated Cells Releasing Nerve Growth Factor
D Ferreira, E Westman, H Eyjolfsdottir, P Almqvist, G Lind, B Linderoth, ...
Journal of Alzheimer's Disease 43 (3), 1059-1072, 2015
722015
Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD
G Spulber, E Niskanen, S MacDonald, M Kivipelto, D Ferreira Padilla, ...
Current Alzheimer Research 9 (4), 516-524, 2012
492012
Cognitive decline is mediated by gray matter changes during middle age
D Ferreira, Y Molina, A Machado, E Westman, LO Wahlund, A Nieto, ...
Neurobiology of aging 35 (5), 1086-1094, 2014
462014
Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy
D Ferreira, O Voevodskaya, K Imrell, L Stawiarz, G Spulber, LO Wahlund, ...
Journal of neuroimmunology 274 (1-2), 149-154, 2014
422014
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease
A Karami, H Eyjolfsdottir, S Vijayaraghavan, G Lind, P Almqvist, A Kadir, ...
Alzheimer's & Dementia 11 (11), 1316-1328, 2015
412015
Improving CSF Biomarkers’ Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer’s Disease by Considering Different Confounding Factors: A Meta-Analysis
D Ferreira, A Rivero-Santana, L Perestelo-Pérez, E Westman, ...
Frontiers in Aging Neuroscience 6 (Article 287), 1-12, 2014
352014
Cerebrospinal fluid biomarkers for the differential diagnosis between Alzheimer’s disease and frontotemporal lobar degeneration: systematic review, HSROC analysis, and …
A Rivero-Santana, D Ferreira, L Perestelo-Perez, E Westman, ...
Journal of Alzheimer's Disease 55 (2), 625-644, 2017
322017
Cognitive decline before the age of 50 can be detected with sensitive cognitive measures
D Ferreira, R Correia, A Nieto, A Machado, Y Molina, J Barroso
Psicothema 27 (3), 216-222, 2015
302015
Repeatability and reproducibility of FreeSurfer, FSL-SIENAX and SPM brain volumetric measurements and the effect of lesion filling in multiple sclerosis
C Guo, D Ferreira, K Fink, E Westman, T Granberg
European radiology 29 (3), 1355-1364, 2019
292019
The effect of age correction on multivariate classification in Alzheimer’s disease, with a focus on the characteristics of incorrectly and correctly classified subjects
F Falahati, D Ferreira, H Soininen, P Mecocci, B Vellas, M Tsolaki, ...
Brain topography 29 (2), 296-307, 2016
282016
Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition
D Ferreira, L Cavallin, T Granberg, O Lindberg, C Aguilar, P Mecocci, ...
European radiology 26 (8), 2597-2610, 2016
272016
Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease
S Thordardottir, AK Ståhlbom, D Ferreira, O Almkvist, E Westman, ...
Journal of Alzheimer's Disease 43 (4), 1393-1402, 2015
262015
The contribution of small vessel disease to subtypes of Alzheimer's disease: a study on cerebrospinal fluid and imaging biomarkers
D Ferreira, S Shams, L Cavallin, M Viitanen, J Martola, T Granberg, ...
Neurobiology of aging 70, 18-29, 2018
252018
A signature pattern of cortical atrophy in dementia with Lewy bodies: a study on 333 patients from the European DLB Consortium
K Oppedal, D Ferreira, L Cavallin, AW Lemstra, M Ten Kate, A Padovani, ...
Alzheimer's & Dementia 15 (3), 400-409, 2019
242019
The A/T/N biomarker scheme and patterns of brain atrophy assessed in mild cognitive impairment
U Ekman, D Ferreira, E Westman
Scientific reports 8 (1), 1-10, 2018
232018
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20